Tag Archive: FDA

FDA clears Fluidda’s Broncholab platform for use in Clinical Practice

March 9, 2020 4:15 pm Published by Fluidda 1 Comment

The US Food and Drug Administration provided market clearance to Fluidda for its Broncholab platform. Broncholab provides a number of Functional Respiratory Imaging (FRI) parameters to physicians via an online... View Article

FDA – FRI acknowledged important tool for investigating deposition

February 10, 2020 4:22 pm Published by Fluidda Leave your thoughts

In a recent article, the Food and Drug Administration (FDA) mentioned Fluidda’s FRI technology as an important tool to investigate regional drug deposition of the extrathoracic region, especially to measure... View Article